WEBINAR ENDED
WEBINAR DETAILS
  • About
    The management will cover recent news related to the pipeline program.

    FluoGuide has decided to expand the design of the phase IIb trial in aggressive brain cancer with 24 patients instead of 12.

    Furthermore, FluoGuide has decided to explore FG001 in phase IIa clinical trials in three other severe cancer indications.
  • Agenda
    • Presentation by FluoGuide's management team
    • Q&A
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Anyone with the event link can attend
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
HOSTED BY
ATTENDED (19)